BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24116159)

  • 1. Migrastatin analogues inhibit canine mammary cancer cell migration and invasion.
    Majchrzak K; Lo Re D; Gajewska M; Bulkowska M; Homa A; Pawłowski K; Motyl T; Murphy PV; Król M
    PLoS One; 2013; 8(10):e76789. PubMed ID: 24116159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of Migrastatin Analogues as Inhibitors of Tumour Cell Migration: Exploring Structural Change in and on the Macrocyclic Ring.
    Lo Re D; Zhou Y; Mucha J; Jones LF; Leahy L; Santocanale C; Krol M; Murphy PV
    Chemistry; 2015 Dec; 21(50):17993. PubMed ID: 26537992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migrastatin analogues target fascin to block tumour metastasis.
    Chen L; Yang S; Jakoncic J; Zhang JJ; Huang XY
    Nature; 2010 Apr; 464(7291):1062-6. PubMed ID: 20393565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel anti-invasive properties of a Fascin1 inhibitor on colorectal cancer cells.
    Montoro-García S; Alburquerque-González B; Bernabé-García Á; Bernabé-García M; Rodrigues PC; den-Haan H; Luque I; Nicolás FJ; Pérez-Sánchez H; Cayuela ML; Salo T; Conesa-Zamora P
    J Mol Med (Berl); 2020 Mar; 98(3):383-394. PubMed ID: 31996952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactimidomycin, iso-migrastatin and related glutarimide-containing 12-membered macrolides are extremely potent inhibitors of cell migration.
    Ju J; Rajski SR; Lim SK; Seo JW; Peters NR; Hoffmann FM; Shen B
    J Am Chem Soc; 2009 Feb; 131(4):1370-1. PubMed ID: 19132897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative structure-activity studies on a series of migrastatin analogs as inhibitors of cancer cell metastasis.
    Santos RN; Guido RV; Oliva G; Dias LC; Andricopulo AD
    Med Chem; 2011 May; 7(3):155-64. PubMed ID: 21486209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New role of the antidepressant imipramine as a Fascin1 inhibitor in colorectal cancer cells.
    Alburquerque-González B; Bernabé-García M; Montoro-García S; Bernabé-García Á; Rodrigues PC; Ruiz Sanz J; López-Calderón FF; Luque I; Nicolas FJ; Cayuela ML; Salo T; Pérez-Sánchez H; Conesa-Zamora P
    Exp Mol Med; 2020 Feb; 52(2):281-292. PubMed ID: 32080340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of new migrastatin and dorrigocin congeners unveils cell migration inhibitors with dramatically improved potency.
    Ju J; Rajski SR; Lim SK; Seo JW; Peters NR; Hoffmann FM; Shen B
    Bioorg Med Chem Lett; 2008 Nov; 18(22):5951-4. PubMed ID: 18684620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Therapeutic Potential of Migrastatin-Core Analogs for the Treatment of Metastatic Cancer.
    Giralt E; Lo Re D
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28208778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of Migrastatin Analogues as Inhibitors of Tumour Cell Migration: Exploring Structural Change in and on the Macrocyclic Ring.
    Lo Re D; Zhou Y; Mucha J; Jones LF; Leahy L; Santocanale C; Krol M; Murphy PV
    Chemistry; 2015 Dec; 21(50):18109-21. PubMed ID: 26531227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent cell migration inhibitors through total synthesis: lessons from structure-activity studies of (+)-migrastatin.
    Njardarson JT; Gaul C; Shan D; Huang XY; Danishefsky SJ
    J Am Chem Soc; 2004 Feb; 126(4):1038-40. PubMed ID: 14746469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of novel migrastatin and dorrigocin A analogues from D-glucal.
    Anquetin G; Rawe SL; McMahon K; Murphy EP; Murphy PV
    Chemistry; 2008; 14(5):1592-600. PubMed ID: 18038383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The migrastatin family: discovery of potent cell migration inhibitors by chemical synthesis.
    Gaul C; Njardarson JT; Shan D; Dorn DC; Wu KD; Tong WP; Huang XY; Moore MA; Danishefsky SJ
    J Am Chem Soc; 2004 Sep; 126(36):11326-37. PubMed ID: 15355116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice.
    Shan D; Chen L; Njardarson JT; Gaul C; Ma X; Danishefsky SJ; Huang XY
    Proc Natl Acad Sci U S A; 2005 Mar; 102(10):3772-6. PubMed ID: 15728385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverted total synthesis leads to the generation of promising cell-migration inhibitors for treatment of tumor metastasis: in vivo and mechanistic studies on the migrastatin core ether analog.
    Oskarsson T; Nagorny P; Krauss IJ; Perez L; Mandal M; Yang G; Ouerfelli O; Xiao D; Moore MA; Massagué J; Danishefsky SJ
    J Am Chem Soc; 2010 Mar; 132(9):3224-8. PubMed ID: 20155906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of potent inhibitors of metastasis in lung cancer via syntheses based on migrastatin.
    Lecomte N; Njardarson JT; Nagorny P; Yang G; Downey R; Ouerfelli O; Moore MA; Danishefsky SJ
    Proc Natl Acad Sci U S A; 2011 Sep; 108(37):15074-8. PubMed ID: 21808037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migrastatin, a new inhibitor of tumor cell migration from Streptomyces sp. MK929-43F1. Taxonomy, fermentation, isolation and biological activities.
    Nakae K; Yoshimoto Y; Sawa T; Homma Y; Hamada M; Takeuchi T; Imoto M
    J Antibiot (Tokyo); 2000 Oct; 53(10):1130-6. PubMed ID: 11132958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The geodiamolide H, derived from Brazilian sponge Geodia corticostylifera, regulates actin cytoskeleton, migration and invasion of breast cancer cells cultured in three-dimensional environment.
    Freitas VM; Rangel M; Bisson LF; Jaeger RG; Machado-Santelli GM
    J Cell Physiol; 2008 Sep; 216(3):583-94. PubMed ID: 18330887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monastrol suppresses invasion and metastasis in human colorectal cancer cells by targeting fascin independent of kinesin-Eg5 pathway.
    Alburquerque-González B; Montoro-García S; Bernabé-García Á; Bernabé-García M; Campioni-Rodrigues P; Rodríguez-Martínez A; Luque I; Salo T; Pérez-Garrido A; Pérez-Sánchez H; Cayuela ML; Luengo-Gil G; Luchinat E; Postigo-Corrales F; Staderini T; Nicolás FJ; Conesa-Zamora P
    Biomed Pharmacother; 2024 Jun; 175():116785. PubMed ID: 38781869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β1 induced fascin1 expression facilitates the migration and invasion of kidney carcinoma cells through ERK and JNK signaling pathways.
    Yang J; Zhang N; Gao R; Zhu Y; Zhang Z; Xu X; Wang J; Li Z; Liu X; Li Z; Li J; Bi J; Kong C
    Biochem Biophys Res Commun; 2018 Jul; 501(4):913-919. PubMed ID: 29772238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.